Pancreatic carcinoma is characterized by mutations and/or silencing of tumor suppressor genes, as TP53 and Smad4, mutation of KRAS and overexpression of receptor tyrosine kinases (RTKs) such as EFGR, VEGFR, IGF-1R, and RON. The gene discussed is KRAS; the disease is exocrine pancreatic carcinoma.